Mineralocorticoid receptor antagonists reduce risk of cardiovascular events in patients with heart failure Post author: Post published:September 3, 2024 Post category:uncategorized MRAs significantly lower the risk of cardiovascular death and HF hospitalization in heart failure patients. You Might Also Like Researchers develop new antibody with potential to treat several types of cancer November 11, 2024 Circulating microRNAs likely as effective as A1C for predicting type 2 diabetes in youth June 24, 2024 Study reveals how DNA gyrase resolves DNA entanglements April 12, 2024
Circulating microRNAs likely as effective as A1C for predicting type 2 diabetes in youth June 24, 2024